The Flowr Corporation’s (TSX.V: FLWR) (OTC: FLWPF)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
1,251
The Flowr Corporation’s (TSX.V: FLWR) (OTC: FLWPF) Medical Cannabis Products are Now Available on Shoppers Drug Mart’s Online Store

- Shoppers Drug Mart is now the exclusive direct-to-patient online provider of FlowrRx products
- The agreement between Flowr Corporation and Shoppers Drug Mart is expected to solidify Flowr’s leading position in the Canadian medicinal cannabis market
- Flowr is already a leader in terms of high yields and low production costs – two factors that are proving to be determining for the success of cannabis companies

FlowrRX products by The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) are now available for purchase through the Shoppers Drug Mart online medical cannabis platform, as the company announced on March 18, 2019 (http://nnw.fm/c39Vv).

The two companies confirmed a sales agreement at the beginning of 2019. Through the partnership, The Flowr Corporation and Shoppers Drug Mart are simplifying the delivery of medical cannabis products in Canada.

“Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced GMP designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies Flowr’s role in Canada’s medical cannabis landscape,” co-CEO Vinay Tolia said in a news release.

To order FlowerRX products, patients are required to submit a completed medical document from a health care practitioner to Shoppers Drug Mart. Company advisers will next contact the health care practitioner to verify the document and ensure the immediate completion of the order.

Previously, FlowrRX products were available via the Flowr online store. As per a 2019 agreement, Shoppers Drug Mart is now the exclusive direct-to-patient distributor of FlowrRX products.

Featuring premium quality medicinal cannabis, the FlowrRX range of offerings is the result of Flowr Corporation’s research and development team focusing on innovative cultivars and the creation of unique products. High quality customer service is another key to the delivery of reliable solutions under the FlowrRX brand.

The FlowrRX premium product delivery program incorporates the use of multiple strains ranging from high THC to more balanced options and featuring the company’s BC Delahaze. Delahaze is an award-winning cultivar known for the strong invigorating effect. The cultivar is grown in the Flowr Corporation’s indoor facility to put emphasis on both potency and flavor through consistent control over the cultivation process.

Flowr Corporation is a Health Canada Licensed Producer of cannabis under the Access to Cannabis for Medical Purposes Regulations. The company is emerging as a Canadian leader in the field as a result of its highly advanced, purpose-built cultivation facilities.

Through its innovative cultivation practices, Flowr consistently generates the high crop yields needed for the delivery of premium and ultra-premium cannabis products.

Control over cultivation and innovative practices result in a cost-efficient cultivation process. As the company notes, high yields per square foot are key to ensuring low operating costs and profitability.

For more information, visit the company’s website at www.Flowr.ca

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skyven's Heat Pump Sets New Steam Efficiency Benchmark

Updated Category News Views 3

The Efficiency Game-Changer in Industrial Steam Swinging in like a seasoned market shake-up is Skyven Technologies, raising eyebrows—and interest—by nailing a coefficient of performance (COP) of 8.0 for their Arcturus heat pump. You don't have to be a market wizard to know that's a big leap from the initial COP of 6.5. It's more than just numbers on a page; this...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Geek+ Spurs Growth with 35.5% Order Surge and New Model

Updated Category News Views 2

Unexpected Surge in Orders Drives Geek+ It looks like Geek+ isn't just playing around in the robotics sandbox anymore. They're delivering some serious results, reporting a 35.5% increase in new signed orders reaching a whopping RMB2.385 billion for the first half of 2026. That's not chump change, and it injects a healthy dose of optimism into their future performance...

Continue Reading
Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Updated Category News Views 0

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 2

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
California's Annual Recovery Happens Event Unites Community

Updated Category News Views 2

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

Continue Reading
Wahl's Bold Move: The Baldscaper™ Revolution

Updated Category News Views 2

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Continue Reading
Common Threads Takes Nutrition Education Digital in 2026

Updated Category News Views 4

Digitizing 23 Years of Nutrition Know-How Common Threads has been in the trenches for over two decades, teaching kids and families how to eat right and cook healthier meals. Now, the nonprofit's dragging its vast experience into the digital realm, rolling out a beefed-up version of its TEACH platform this September 15th. Through new certificate courses in Nutrition...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 1

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Sector Gains Momentum as Market Reacts to Rate Cuts

Updated Category News Views 63

Market Overview: Modest Gains and Trader Optimism As the week kicks off, U.S. index futures are showing slight upticks, signaling that traders remain hopeful despite waning enthusiasm from the recent rate cuts. There's a growing expectation that the technology sector will support the market, especially with recent developments involving Intel Corp (NASDAQ: INTC)....

Continue Reading
BDA Strengthens Portfolio with Acquisition of Harper + Scott

Updated Category News Views 944

BDA Strengthens Portfolio with Acquisition of Harper + Scott Deal Grows BDA's Roster of Enterprise Customers, Unites Top Branded Merchandise Agencies Bensussen Deutsch & Associates, LLC (BDA), the nation's leading Merchandise Agency™ for iconic brands including Major League Baseball, Johnson & Johnson, and The Home Depot, has acquired Harper + Scott, a creative branded...

Continue Reading
Mexco Energy Corporation Achieves Growth Amid Oil Price Challenges

Updated Category News Views 170

Mexco Energy Corporation Reports Impressive Financial Performance Mexco Energy Corporation (NYSE American: MXC), based in Midland, Texas, has reported notable financial results for the recently concluded six-month period. The company has achieved a net income of $565,457, translating to $0.27 per diluted share for the interim period ending September 30. Operating Revenues...

Continue Reading
Exciting Developments in (Z)-Endoxifen Research at SABCS 2025

Updated Category News Views 167

Atossa Therapeutics' Bold Moves in Breast Cancer Treatment Atossa Therapeutics, Inc. (NASDAQ: ATOS) is making waves in the oncology sector, focusing on innovative therapies for breast cancer. The company has recently announced that four abstracts on (Z)-endoxifen have been accepted for presentation at the renowned San Antonio Breast Cancer Symposium (SABCS), scheduled for...

Continue Reading
JPMorgan Global Growth & Income Adds New Ordinary Shares

Updated Category News Views 202

JPMorgan Global Growth & Income Expands Share Capital Recently, JPMorgan Global Growth & Income Plc took an important step by issuing 100,000 new Ordinary Shares priced at 581.70 pence each. This decision to issue additional shares aligns with the company’s ongoing strategy to enhance its operational capacity and foster growth. Impact on Share Capital This issuance has...

Continue Reading